Status:
RECRUITING
Serum Collection Study for Assay Development
Lead Sponsor:
GPN Vaccines
Conditions:
Pneumococcal Disease, Invasive
Pneumococcal Disease
Eligibility:
All Genders
18-69 years
Phase:
PHASE1
Brief Summary
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Detailed Description
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation Participants will receive a dose of Gamma-PN and serum will be collected pre...
Eligibility Criteria
Inclusion
- good general health
Exclusion
- no previous pneumococcal vaccine
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT07205289
Start Date
October 1 2025
End Date
June 1 2026
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Adelaide Clinical Research Facility
Adelaide, South Australia, Australia, 5000